Figure 3
From: Absence of relevant QT interval prolongation in not critically ill COVID-19 patients
Panel A. Representation of QTc interval at baseline (at treatment initiation) and at follow-up (at least 48 h on treatment). The median of the baseline QTc was 416 (404–433) ms; after treatment QTc was prolonged to 423 (405–438) ms. Panel B. Distribution of patients according to the percentage increase of the QT interval with respect to the basal. The vast majority of patients presented a mild (0–9.9%) raise in QTc during treatment.
